Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy

Abstract Recent clinical trials have found that the serotonergic psychedelic psilocybin effectively alleviates anxiodepressive symptoms in patients with life-threatening illnesses when given in a supportive environment. These outcomes prompted Canada to establish legal pathways for therapeutic acces...

Full description

Bibliographic Details
Main Authors: Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara Gloeckler, David Erritzoe, Robin Carhart-Harris, Kyle T. Greenway
Format: Article
Language:English
Published: Nature Portfolio 2024-07-01
Series:Scientific Reports
Subjects:
Psychedelics
Psilocybin-assisted psychotherapy
Distress
Palliative care
Online Access:https://doi.org/10.1038/s41598-024-66817-0

Internet

https://doi.org/10.1038/s41598-024-66817-0

Similar Items